NEW WAYS OF TREATING PERENNIAL ALLERGIC RHINITIS

Abstract

Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov Selecting the proper treatment of perennial allergic rhinitis (PAR) today is often unsuccessful. At present, PAR is characterized by the early beginning, quite often continuously relapsing course and resistance to antiallergic therapy. Study of the mechanisms of the course of the disease creates a basis for the rational therapy that assumes impact on the composite inflammatory response, not only on allergy symptoms. Aim - to reflect the importance of a modern approach to treatment of patients with perennial allergic rhinitis. Materials and methods. For analysis we decided to conduct a comparative study of monotherapy with topical glucocorticosteroids and combined therapy consisting of topical glucocorticosteroids together with intranasal antihistamine medications. Results. The research showed that the use of the combined therapy with topical glucocorticosteroids and intranasal antihistamine medications can be effective in patients with perennial allergic rhinitis, considerably improving the quality of life.

Keywords

• allergy
• allergic rhinitis
• intranasal glucocorticosteroids
• mometasone
• azelastine